JPRN-UMIN000012947
Suspended
未知
Effects of atomoxetine on cognitive functions in normal subjects using fMRI - Effects of atomoxetine on cognitive functions in normal subjects using fMRI
ippon Medical School0 sites25 target enrollmentJanuary 24, 2014
ConditionsHealthy adults
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Healthy adults
- Sponsor
- ippon Medical School
- Enrollment
- 25
- Status
- Suspended
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Subjects with drug allergy. Subjects with cardiovascular disorder, glaucoma, liver and renal dysfunction, urination difficulty. Subjects with history of pheochromocytoma, convulsive seizure, hypertension, cerebrovascular disorder, orthostatic hypotension. Subjects taking any drug within 1 week. Subjects with contraindications to MRI. Subjects who are judged as not suitable for participation in this study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
The effect of Atomoxetine on Cognitive Function of Multiple SclerosisMultiple Sclerosis.Demyelinating disease of central nervous system, unspecifiedG37.9IRCT20210715051901N1Ahvaz University of Medical Sciences52
Recruiting
Phase 3
The Effect of Atomoxetine on Cognitive Symptoms in Schizophrenia PatientsIRCT20211219053452N1Arak University of Medical Sciences40
Recruiting
Phase 2
Study of the effect of Atomoxetine on cognitive symptoms in patients with schizophreniaIRCT20101130005280N31Mashhad University of Medical Sciences42
Not yet recruiting
Phase 3
Atomoxetine for cognitive impairment in Behcet's diseaseIRCT20211206053288N1Tehran University of Medical Sciences40
Completed
Phase 4
Administration of Paroxetine Attenuates cognitive functon by using fMRI.depressionJPRN-UMIN000002977Tamagawa University30